Buys royalty interests in marketed and late-stage biopharmaceuticals.
Industry: Health Care
First Day Return: +58.9%
Industry: Health Care
IPO Data | |
---|---|
IPO File Date | 05/22/2020 |
Offer Price | $28.00 |
Price Range $25.00 - $28.00 | |
Offer Shares (mm) | 77.7 |
Deal Size ($mm) | $2,175 |
Lock-Up Date | IPO Pro Only |
Street Research | IPO Pro Only |
IPO Data | |
---|---|
IPO Date | 06/15/2020 |
Offer Price | IPO Intelligence Only |
Price Range | IPO Intelligence Only |
Offer Shares (mm) | IPO Intelligence Only |
Deal Size ($mm) | $2,175 |
Lock-Up Date | IPO Intelligence Only |
Street Research | IPO Intelligence Only |
Underwriters |
---|
IPO Intelligence Only |
Company Data | |
---|---|
Headquarters | New York, NY, United States |
Founded | 1996 |
Employees at IPO | 35 |
Website www.royaltypharma.com |